The 'Block 5' rocket is the first Falcon 9 rocket that can theoretically be reused 10 times without any maintenance, and up to 100 times with just minor servicing. If SpaceX can pull off seven successful 'Block 5' launches, the company could get clearance from NASA to do manned missions, says Will Goodman, managing editor of Rockets Are Cool.
For the full interview, [click here](https://cheddar.com/videos/spacexs-falcon-from-the-block-2).
These are the headlines you Need 2 Know for Friday, November 29, 2019.
The region's natural gas utility, Peoples Gas, is spending $30 million to build five gas-fired generating stations that will together churn out 20 megawatts – enough not only for the airport itself but a hotel and gas station that are on-site.
These are the headlines you Need 2 Know for Wednesday, November 27, 2019.
With "no sign of slowdown" in the concentrations of greenhouse gases according to a report by the UN's World Meteorological Organization, the international body renews its call for drastically reducing emissions globally.
These are the headlines you Need 2 Know for Tuesday, November 26, 2019.
Taking a page from V-shaped bird formations, Airbus next year plans to start testing the ability to have two aircraft fly closely together for long-haul trans-Atlantic flights.
The Growing Renewable Energy and Efficiency Now (or GREEN) Act would add five years to the so-called investment tax credit (ITC) that provides an upfront subsidy to solar and offshore wind projects.
Cheddar spoke to Mike Massimino, former NASA astronaut and senior advisor for space programs at the Intrepid Museum, to get his take on films such as "Apollo 13" and "Gravity."
The sold out event marked progress for the industry, and hammered home opportunities ー and challenges ー on the rise in one of the next frontiers for cannabis legalization: the European Union.
New research from the agency, released on Friday, examined lung fluid samples from victims of e-cigarette, or vaping, product use associated lung injury (EVALI) and found vitamin E acetate in 100 percent of samples from 29 patients across 10 states.
